ALGN vs LLY: fair value comparison
Align Technology, Inc. and Eli Lilly and Company · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, ALGN currently sits closer to the top of our ranking by discount to fair value.
| ALGN | LLY | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $142.71 | $1,179.27 |
| 12-month range | $131.91–$197.51 | $813.53–$1,280.34 |
| Rank by discount to fair value | #4 of 108 Healthcare | #9 of 108 Healthcare |
| Quality grade | B | B |
| Momentum grade | — | B |
| Leverage | Low | High |
| Margin trend | Contracting | Expanding |
| Revenue growth | Modest | High |
| RSI zone | Neutral | Overbought |
| 50/200-day trend | Downtrend | — |
| DCF cross-check | Overvalued | — |
| 52-week position | The bottom quarter | The top quarter |
Full single-stock breakdowns: ALGN fair value analysis · LLY fair value analysis